August 2023
Professor Paul Dietze
Dr Ashleigh Stewart

Evidence Brief: Supervised Injecting Facilities

The accumulated global evidence suggests that supervised injecting facilities play a significant role in preventing drug-related deaths and associated harm. Evidence shows how supervised injecting facilities can address health and social challenges associated with drug dependence, benefiting both individuals and communities at large. Evidence presented in this document demonstrates a clear need for a new facility in Melbourne's CBD.


October 2022

Take Home Naloxone National Distribution Resource

The National Naloxone Reference Group (NNRG) has created an infographic to present up-to-date information on take home naloxone access across Australia. This resource will be updated each time the NNRG meets, roughly every two months.


February 2022

Letter to the Minister for Health and Aged Care for THN Pilot

Letter to the Minister for Health and Aged Care concerning the Pharmaceutical Benefits Scheme subsidised Take Home Naloxone (THN) Pilot.


January 2022

National Naloxone Terms of Reference

The purpose of NNRG is to bring together key stakeholders from each state and territory in Australia involved in take home naloxone distribution strategies in Australia.


June 2021
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Ele Morrison
Dr Ashleigh Stewart
Sean Swift
Clint Westig

NSP Snapshots Round 4, March 2021 Results

Results from the fourth round of the NSP Snapshots Study - Results from Access Health St Kilda, Carrington Health and CHOPER Box Hill, North Richmond Community Health, cohealth Braybrook, Healthworks Footscray, and Star Health Prahran


October 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Clint Westig

NSP Snapshots Round 3, September 2020 Results - All services

Results from the third round of the NSP Snapshots Study - results from Access Health St Kilda, Carrington Health and CHOPER Box Hill, North Richmond Community Health, cohealth Braybrook and Healthworks Footscray


October 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 3, September 2020 Results - Access Health St Kilda

Results from the third round of the NSP Snapshots Study - results from Access Health St Kilda


October 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 3, September 2020 Results - Carrington Health and CHOPER

Results from the third round of the NSP Snapshots Study - results from Carrington Health and CHOPER Box Hill


October 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 3, September 2020 Results - NRCH

Results from the third round of the NSP Snapshots Study - results from North Richmond Community Health


October 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 3, September 2020 Results - cohealth

Results from the third round of the NSP Snapshots Study - results from cohealth Braybrook and Healthworks Footscray


September 2020
Professor Paul Dietze
Penny Hill

NNRG Take Home Naloxone resource - Background Information

The National Naloxone Reference Group (NNRG) has created an infographic to present up-to-date information on take home naloxone access across Australia. This resource will be updated each time the NNRG meets, roughly every two months.


July 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 2, June 2020 Results - All services

Results from the second round of the NSP Snapshots Study - results from Access Health St Kilda, Carrington Health and CHOPER Box Hill, North Richmond Community Health, cohealth Braybrook and Healthworks Footscray


July 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 2, June 2020 Results - Access Health

Results from the second round of the NSP Snapshots Study - results from Access Health St Kilda.


July 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 2, June 2020 Results - Carrington Health

Results from the second round of the NSP Snapshots Study - results from Carrington Health and CHOPER Box Hill


July 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 2, June 2020 Results - NRCH

Results from the second round of the NSP Snapshots Study - results from North Richmond Community Health


July 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 2, June 2020 Results - cohealth Braybrook

Results from the second round of the NSP Snapshots Study - results from cohealth Braybrook


July 2020
Debra Alexander
Shelley Cogger
Sione Crawford
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Sean Swift
Rebecca Thatcher
Clint Westig

NSP Snapshots Round 2, June 2020 Results - Healthworks Footscray

Results from the second round of the NSP Snapshots Study - results from Healthworks Footscray


May 2020
Michael Curtis
Professor Paul Dietze
Penny Hill
Danny Jeffcote
Rebecca Thatcher

NSP Snapshots Round 1, February 2020 Results

Results from the first round of the NSP Snapshots Study - results from Access Health St Kilda and Healthworks Footscray.


October 2019
Michael Curtis
Professor Paul Dietze
Amy Kirwan
Shelley Walker
Emma Woods

St Kilda 24-Hour NSP Evaluation Report 2018

The Salvation Army commissioned Burnet Institute to gather data on its 24-hour needle and syringe program (NSP) in St Kilda, Victoria, Australia. Uniquely in Victoria, the St Kilda NSP is funded to run a staffed service 24 hours a day, seven days a week, and has been in operation with this model for over 10 years.


September 2018

Symposium 2018: Dr Debbie Scott (Video)

Setting the scene: Trends in opioid overdoses attended by Ambulance Victoria - Dr Debbie Scott - Strategic Lead, Population Health Research, Turning Point; Senior Research Fellow, Monash University


September 2018

Symposium 2018: Sarah Hiley (Video)

The Melbourne Medically Supervised Injecting Room: Another piece of the puzzle in reducing overdose deaths - Sarah Hiley - Harm Reduction Practitioner Team Leader, Medically Supervised Injecting Room, North Richmond Community Health


September 2018

Symposium 2018: Sione Crawford (Video)

Peer-led overdose response work and broader peer perspectives - Sione Crawford - Executive Officer, Harm Reduction Victoria


September 2018

Symposium 2018: Dr Renae Fomiatti (Video)

Addiction stigma and the production of impediments to take-home naloxone uptake - Dr Renae Fomiatti - Research Officer, National Drug Research Institute


September 2018

Symposium 2018: Associate Professor Suzanne Nielsen (Video)

Naloxone supply and overdose prevention in mainstream healthcare services - Associate Professor Suzanne Nielsen - Deputy Director, Monash Addiction Research Centre (MARC)


September 2018

Symposium 2018: Dr Stephen McNally (Video)

Take-home naloxone: Insights from existing international models - Dr Stephen McNally, Deputy CEO, Penington Institute


September 2018

Symposium 2018: Dr Debbie Scott (Slides)

Setting the scene: Trends in opioid overdoses attended by Ambulance Victoria - Dr Debbie Scott - Strategic Lead, Population Health Research, Turning Point; Senior Research Fellow, Monash University


September 2018

Symposium 2018: Sarah Hiley (Slides)

The Melbourne Medically Supervised Injecting Room: Another piece of the puzzle in reducing overdose deaths - Sarah Hiley - Harm Reduction Practitioner Team Leader, Medically Supervised Injecting Room, North Richmond Community Health


September 2018

Symposium 2018: Sione Crawford (Slides)

Peer-led overdose response work and broader peer perspectives - Sione Crawford - Executive Officer, Harm Reduction Victoria


September 2018

Symposium 2018: Dr Renae Fomiatti (Slides)

Addiction stigma and the production of impediments to take-home naloxone uptake - Dr Renae Fomiatti - Research Officer, National Drug Research Institute


September 2018

Symposium 2018: Associate Professor Suzanne Nielsen (Slides)

Naloxone supply and overdose prevention in mainstream healthcare services - Associate Professor Suzanne Nielsen - Deputy Director, Monash Addiction Research Centre (MARC)


September 2018

Symposium 2018: Dr Stephen McNally (Slides)

Take-home naloxone: Insights from existing international models - Dr Stephen McNally- Deputy CEO, Penington Institute


September 2018
Rebecca Winter

PhD Completion Report - Dr Rebecca Winter

CREIDU PhD Completion Report_Winter


September 2018
Rachel Sacks-Davis

PhD Completion Report - Dr Rachel Sacks-Davis

PhD Completion Report - Dr Rachel Sacks-Davis


September 2018
Dhanya Nambiar

PhD Completion Report - Dr Dhanya Nambiar

PhD Completion Report - Dr Dhanya Nambiar


September 2018
Danielle Horyniak

PhD Completion Report - Dr Danielle Horyniak

PhD Completion Report - Dr Danielle Horyniak


September 2018
Renae Fomiatti

PhD Completion Report - Dr Renae Fomiatti

PhD Completion Report - Dr Renae Fomiatti


September 2018
Doctor Joseph Doyle

PhD Completion Report - Dr Joseph Doyle

PhD Completion Report - Dr Joseph Doyle


September 2018
Maryam Alavi

PhD Completion Report - Dr Maryam Alavi

PhD Completion Report - Dr Maryam Alavi


November 2016

Opioid Overdose Action Plan

Pharmacy Guild's pamphlet on how to respond to an opioid overdose, including information on minijets and ampoules.


November 2016

Naloxone Ampules Resources

Penington Institute Resource on Naloxone Ampules. More resources available here: http://www.copeaustralia.com.au/resources/


September 2016

CREIDU Colloquium 2016: Ms Jane Dicka

CREIDU Colloquium presentation by Ms Jane Dicka: The DOPE Project - where's it been and where's it going?


September 2016

CREIDU Colloquium 2016: Dr Suzanne Nielsen

CREIDU Colloquium presentation by Dr Suzanne Nielsen: "Scaling up community pharmacy supply of naloxone"


September 2016
Professor Paul Dietze

CREIDU Colloquium 2016: Professor Paul Dietze

CREIDU Colloquium presentation by Professor Paul Dietze: "Naloxone supply in the short, medium and long term: Implications for take-home naloxone programs in Australia"


September 2016

CREIDU Colloquium 2016: Professor Nicholas Lintzeris

CREIDU Colloquium presentation by Professor Nicholas Lintzeris: "Translating take-home naloxone from a good idea to mainstream practice across drug and alcohol, Needle and Syringe Program and peer worker settings in New South Wales"


September 2016

CREIDU Colloquium 2016: Mr Crios O'Mahony

CREIDU Colloquium presentation by Mr Crios O'Mahony: "The COPE program: Getting naloxone into the hands of potential overdose witnesses across Victoria"


April 2016

NPS MedicineWise Online Learning Tool for GPs to manage hepatitis C

Online training module on diagnosis, treatment and ongoing management of people with chronic hepatitis C infection.


March 2016
Professor Gregory Dore
Doctor Joseph Doyle
Professor Margaret Hellard
Doctor Alex Thompson

Australian recommendations for the management of hepatitis C virus infection: a consensus statement

The consensus statement was prepared by an expert panel representing the Gastroenterological Society of Australia (Australian Liver Association), the Australasian Society for Infectious Diseases, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, the Australasian Hepatology Association, Hepatitis Australia and the Royal Australian College of General Practitioners


October 2015
John Ryan

Video: Prison needle exchange: Fact and fantasy

CREIDU Colloquium 2015 - Mr John Ryan, Penington Institute, Australia

Colloquium 2015
Colloquium


October 2015

Video: Through the eye of a needle behind bars

CREIDU Colloquium 2015 - Dr Eliot Ross Albers, Executive Director of the International Network of People Who Use Drugs

Colloquium 2015
Colloquium


October 2015

Slides: Scotland’s National Naloxone Programme: The Scottish Prison Service provision of naloxone-on-release

CREIDU Colloquium 2015 - Ms Kirsten Horsburgh, National Naloxone Coordinator, Scottish Drugs Forum, Scotland

Colloquium 2015
Colloquium


October 2015

Slides: Treatment of hepatitis within the Victorian prison system – a new model of care

CREIDU Colloquium 2015 - Professor Alexander Thompson, St. Vincent’s Hospital, Australia

Colloquium 2015
Colloquium


October 2015

Slides: Treatment and prevention of hepatitis C in the prison setting

CREIDU Colloquium 2015 - Professor Andrew Lloyd, University of New South Wales, Australia

Colloquium 2015
Colloquium


October 2015

Slides: Harm reduction in prison: How Australia compares to the rest of the world

CREIDU Colloquium 2015 - Professor Kate Dolan, University of New South Wales, Australia

Colloquium 2015
Colloquium


October 2015

Slides: The complexities of harm reduction in custodial settings

CREIDU Colloquium 2015 - Ms Larissa Strong, Department of Justice & Regulation, and Mr Rod Wise, Corrections Victoria, Australia

Colloquium 2015
Colloquium


October 2015

Slides: Prison needle exchange: Fact and fantasy

CREIDU Colloquium 2015 - Mr John Ryan, Penington Institute, Australia

Colloquium 2015
Colloquium


October 2015

Slides: Using positive strategies as a pathway out of the criminal justice system

CREIDU Colloquium 2015 - Ms Carol Nikakis, Victorian Association for Care and Resettlement of Offenders, Australia

Colloquium 2015
Colloquium


October 2015

Video: CREIDU Colloquium 2015 - Kirsten Horsburgh Keynote Address - Part 1

Scotland’s National Naloxone Programme: The Scottish Prison Service provision of naloxone-on-release

Colloquium 2015
Colloquium


October 2015

Video: CREIDU Colloquium 2015 - Kirsten Horsburgh Keynote Address - Part 2

Ms Kirsten Horsburgh, National Naloxone Coordinator, Scottish Drugs Forum, Scotlan

Colloquium 2015
Colloquium


October 2015

CREIDU Colloquium 2015 - Program

Program for the 2015 CREIDU Colloquium, Oct 12: Prisons: Opportunities and challenges towards improving the health of people who inject drugs

Colloquium 2015
Colloquium


September 2015

Colloquium 2015: Flyer

Prisons: Opportunities and challenges towards improving the health of people who inject drugs

Colloquium 2015
Colloquium


August 2015
Professor Paul Dietze


October 2014

Naloxone in Australia Workshop - Flyer

CAHMA, WASUA, Harm Reduction Vic and QUIHN have combined to put together a three part workshop showcasing peer-based naloxone and overdose prevention training specifically for drug and alcohol workers.


August 2014
Professor Gregory Dore

Recent HCV treatment developments: in pursuit of perfectovir!

2014 CREIDU Colloquium presentation by Professor Gregory Dore, Kirby Institute, University of New South Wales, Australia.


August 2014
Professor Frederick Altice

HIV treatment as prevention for people who inject drugs: Lessons learned and implications for HCV

2014 CREIDU Colloquium presentation by Professor Frederick L. Altice, Yale University, USA.


August 2014
Doctor Nicolas Clark

Implications of new hepatitis C treatments for WHO activities related to people who inject drugs

2014 CREIDU Colloquium presentation by Dr Nicolas Clark, World Health Organization, Switzerland


August 2014
Jack Wallace

The perspective of a person with HCV on new treatments and treatment as prevention

2014 CREIDU Colloquium presentation by Mr Jack Wallace, Australian Research Centre in Sex, Health and Society, Australia.


August 2014
Doctor Niklas Luhmann

Treatment as prevention in resource-limited settings: challenges and opportunities

2014 CREIDU Colloquium presentation by Dr Niklas Luhmann, Médecins du Monde, France.


August 2014
Professor Andrew Lloyd

SToP-C: Surveillance and treatment of prisoners with hepatitis C

2014 CREIDU Colloquium presentation by Professor Andrew Lloyd, University of New South Wales, Australia.


August 2014
Professor Peter Vickerman

Modelling HIV and HCV treatment as prevention amongst injecting drug users (and other high risk groups)

2014 CREIDU Colloquium presentation by Professor Peter Vickerman, University of Bristol, England.


July 2014

Hepatitis C preferred terminology for the media

The information in this factsheet has been provided by Hepatitis Australia to assist media in providing balanced reporting on hepatitis C and related issues which is respectful to people affected by hepatitis C.


July 2014

CREIDU AIDS 2014 Satellite Symposium Flyer

Flyer for the CREIDU Satellite Symposium at AIDS 2014 - Controversies in treatment as prevention among people who inject drugs


June 2014

CREIDU Colloquium Flyer 2014

Flyer for the CREIDU Colloquium - HIV and hepatitis C treatment as prevention in people who inject drugs: The promise, the pitfalls and the public health benefits.


June 2014

Yarra City Council letter

This letter acknowledges the recommendations stemming from the North Richmond Public Injecting Impact Study. The Council supports or has taken action across all thirteen recommendations.


May 2014

Call to action to scale up global hepatitis response

This Call to Action was prepared by the World Health Organisation after the Global Partners' Meeting on Hepatitis (Convened by WHO in March 2014 in Geneva). The WHO believes this is a powerful tool to raise the visibility of viral hepatitis globally and to demonstrate shared commitment.


May 2014

Seminar presented by Sheila Bird - Flyer

Information flyer for record-linkage Seminar on June 30, 2014.


May 2014

Two Hep C Questions: What will happen to me? Should I go on treatment?

This informative booklet from Hepatitis NSW provides a guide to long term hepatitis C health outcomes, treatments and liver care. It is intended for use by people affected by hepatitis C and their GP, liver specialist or treatment CNC (Clinical Nurse Consultant).


April 2014

Summary of scientific evidence - The levels of use of opioids, amphetamines and cocaine and associated levels of harm

This EMCDDA report presents the findings of a literature review to identify the most frequently occurring patterns of use and their relation to harm in users of opioids, powder and crack cocaine, and meth/amphetamine.


April 2014

OxyContin Harm Reduction Fact Sheet

A new formulation of the opioid analgesic OxyContin is replacing existing Australian stocks of the medication from April 1, 2014. The new formulation is designed to prevent injecting. This fact sheet (thanks to Sydney's Medically Supervised Injecting Centre, AIVL and WASUA) includes some brief harm reduction information for individuals, family members and workers.


February 2014


February 2014

Introduction to current issues on HIV/AIDS in older adults

Issue of Psychology and AIDS Exchange Newsletter addressing some of the complex and evolving mental health needs of older adults living with HIV. Includes introduction by Timothy G. Heckman.


February 2014

Recommendations for Testing, Managing, and Treating Hepatitis C

To provide healthcare professionals with timely guidance, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) in collaboration with the International Antiviral Society-USA (IAS-USA) have developed a web-based process for the rapid formulation and dissemination of evidence-based, expert-developed recommendations for hepatitis C management.


February 2014

CDC Viral Hepatitis Fact Sheets

CDC has numerous fact sheets on hepatitis A, hepatitis B, hepatitis C, and hepatitis in special populations. Many of the fact sheets are available in other languages. There is a complete list of all available fact sheets that is updated whenever new fact sheets or translations are added.


February 2014

CDC Viral Hepatitis Posters

CDC has multiple hepatitis posters available for ordering at no cost. Some posters are available in other languages.


February 2014

MMWR - CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management

This report provides CDC guidance for persons working, training, or volunteering in health-care settings who have documented HepB vaccination years before hire or matriculation.


September 2013
Professor John Strang

'Overdose & naloxone' keynote presentation video by Prof John Strang (UK)

Professor John Strang, Head of the Addictions Department, King’s College London presented at the 2013 CREIDU Colloquium focusing on injecting related harms. Click below to see his excellent presentation.


August 2013
Nicole Wiggins

'Implementing Expanded Naloxone Availability in the ACT Training Program' presentation slides

Nicole Wiggins, Manager of the Canberra Alliance for Harm Minimisation & Advocacy presented at this year's annual Colloquium on "Implementing an Expanded Naloxone Availability in the ACT Training Program".


August 2013
Carrie Fowlie

'Expanded naloxone availability in the ACT- barriers and enablers' presentation slides

Carrie Fowlie, Executive officer of the Alcohol, Tobacco & Other Drug Association ACT, spoke at our 2013 Annual Colloquium on the experience of implementing expanded naloxone availability in the ACT, detailing the barriers, enablers and how other jurisdictions can begin to expand availability of naloxone right now.


August 2013
Associate Professor Ingrid van Beek

'Targeted primary health care- a foundation to reduce injecting-related harms' presentation slides- Ingrid van Beek

Assoc. Professor Ingrid van Beek presented at this year's Colloquium on "Targeted primary health care- a foundation to reduce injecting-related harms". She covers the story of the Kirkton Road Centre, a primary health care facility established in Sydney in 1987, involved in the prevention, treatment and care of HIV/AIDS and other transmissible infections among ‘at risk’ young people, sex workers and people who inject drugs.


August 2013
Emily Carey
Kaspian Fitzpatrick

'Injecting related harms and injuries' presentation slides

Kaspian Fitzpatrick, Community Health Worker, and Emily Carey, Community Health Nurse, presented at this year's CREIDU Colloquium on injecting related harms and injuries seen at Health Works, a primary health service in the wetern suburbs of melbourne for people who inject drugs.


August 2013

'Injecting related injuries and diseases from a drug user perspective' - presentation slides

Jenny Kelsell, Executive Officer from harm Reduction Victoria, presented at this year's CREIDU Colloquium on injecting related injuries and diseases from a drug user perspective.


May 2013
Professor Paul Dietze
Doctor Robyn Dwyer
Professor Robert Power

North Richmond Public Injecting Impact Study. Community Report

Download the recent report on research conducted by the Burnet Institute in partnership with the Yarra Drug and Health Forum, the City of Yarra, and North Richmond Community Health Centre, and funded by the Centre for Research Excellence into Injecting Drug Use (CREIDU), into the impact of public injecting in Melbourne's inner suburbs. The report details the methodology, main findings and 13 key recommendations to address the issue.


September 2012
Professor Michael Levy

Prisoner Health is Public Health

Click below to download copies of slides presented by Professor Michael Levy at the "Prisoner Health is Public Health" Symposium in 2012.


September 2012
Professor Tony Butler

National Prison Entrants Bloodborne Virus and Risk Behaviour Survey (NPEBBVS)

Click below to download copies of slides presented by Professor Tony Butler at the "Prisoner Health is Public Health" Symposium in 2012.


September 2012
Professor Stuart Kinner

Reducing injection related harm in recently released prisoners

Click below to download copies of slides presented by Associate Professor Stuart Kinner at the "Prisoner Health is Public Health" Symposium in 2012.


September 2012
Professor Lisa Maher

Impact of conditional cash transfers on hepatitis B vaccination completion in people who inject drugs: The Hepatitis B Acceptability and Vaccination Incentives Trial (HAVIT)

Click below to download copies of slides presented by Professor Lisa Maher at the CREIDU 2012 Colloquium "What’s New in Viral Hepatitis and Injecting Drug Use".


September 2012
Professor Frederick Altice

Hepatitis C and strategies to treat hepatitis C among patients with substance use disorders

Click below to download copies of slides presented by Professor Frederick Altice at the CREIDU 2012 Colloquium "What’s New in Viral Hepatitis and Injecting Drug Use"


September 2011
Professor Margaret Hellard
Professor Paul Dietze
Professor Stuart Kinner
Trevor King
Professor Louisa Degenhardt

Heroin and other opioids

This article, published in Prevention Research Quarterly (an Australian Drug Foundation publication) covers trends in and consequences of heroin and other opioid use in use, and contemporary approaches to the issue. Click below to download the article from the ADF website.


July 2011
Professor Thomas Kerr

Harm Reduction in Vancouver, Canada: Responding to a Public Health Emergency

Internationally-renowned Professor Thomas Kerr from the British Columbia Centre for Excellence in HIV/AIDS was the Keynote Speaker for the CREDIU Colloquium "Improving Drug Policy & Practice Through Research" in July 2011. Professor Kerr presented on harm reduction efforts in Vancouver, Canada. Follow this link to watch his fascinating 40-minute presentation.